Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBRA: Multi-organ Screening in Antiphospholipid Syndrome
NCT03348306Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Jul 2018
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoints: Brain or cardiac involvement defined by identification of specific criteria visible by MRI at 24 months and Renal damage defined by the identification of a microalbuminuria > 30mg/L at 24 months. Started Jul 2018; status: completed.
Beyond the preview
Go deeper on NCT03348306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03348306.